Vallentuna, Sweden

Martin Haraldsson

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Pharmacia Ab, Pharmacia & Upjohn Ab, Kabi Pharmacia Ab. Active years: 1994-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Haraldsson. Retrieved from https://idiyas.com/inventor/martin-haraldsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • Vallentuna, SE (1994 - 1996)
  • Taby, SE (2000 - 2001)

Company Filing History:


Years Active: 1994-2001

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Martin Haraldsson: Innovator in Pharmaceutical Compounds

Introduction

Martin Haraldsson is a notable inventor based in Vallentuna, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 6 patents to his name, Haraldsson's work has had a meaningful impact on medical science.

Latest Patents

One of Haraldsson's latest patents involves therapeutically active diarylpropylamines and their pharmaceutically acceptable salts. This invention relates to novel compounds of Formula (I), which possess anticholinergic activity. The compounds can be utilized for treating urinary tract incontinence and are prepared through specific methods outlined in the patent. Additionally, he has developed arylcycloalkane carboxylic esters and their pharmaceutical uses, further showcasing his innovative approach to drug development.

Career Highlights

Throughout his career, Martin Haraldsson has worked with prominent companies in the pharmaceutical industry, including Pharmacia AB and Pharmacia & Upjohn AB. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.

Collaborations

Haraldsson has collaborated with several professionals in his field, including Hubert Agback and Leif G. Ahrgren. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Martin Haraldsson stands out as a significant figure in the pharmaceutical industry, with a focus on innovative compounds that address critical health issues. His contributions continue to influence the development of effective treatments in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…